BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37782459)

  • 21. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.
    Jha P; Claudel T; Baghdasaryan A; Mueller M; Halilbasic E; Das SK; Lass A; Zimmermann R; Zechner R; Hoefler G; Trauner M
    Hepatology; 2014 Mar; 59(3):858-69. PubMed ID: 24002947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.
    Frades I; Andreasson E; Mato JM; Alexandersson E; Matthiesen R; Martínez-Chantar ML
    PLoS One; 2015; 10(5):e0124544. PubMed ID: 25993042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation.
    de Conti A; Dreval K; Tryndyak V; Orisakwe OE; Ross SA; Beland FA; Pogribny IP
    Mol Cancer Res; 2017 Sep; 15(9):1163-1172. PubMed ID: 28512251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
    Yamamoto K; Tateishi K; Kudo Y; Sato T; Yamamoto S; Miyabayashi K; Matsusaka K; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Nakai Y; Isayama H; Ikenoue T; Kurokawa M; Fukayama M; Kokudo N; Omata M; Koike K
    Carcinogenesis; 2014 Nov; 35(11):2404-14. PubMed ID: 24947179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase.
    Yang X; Lu X; Lombès M; Rha GB; Chi YI; Guerin TM; Smart EJ; Liu J
    Cell Metab; 2010 Mar; 11(3):194-205. PubMed ID: 20197052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipase.
    Schweiger M; Paar M; Eder C; Brandis J; Moser E; Gorkiewicz G; Grond S; Radner FP; Cerk I; Cornaciu I; Oberer M; Kersten S; Zechner R; Zimmermann R; Lass A
    J Lipid Res; 2012 Nov; 53(11):2307-17. PubMed ID: 22891293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma.
    Tian Y; Wong VW; Wong GL; Yang W; Sun H; Shen J; Tong JH; Go MY; Cheung YS; Lai PB; Zhou M; Xu G; Huang TH; Yu J; To KF; Cheng AS; Chan HL
    Cancer Res; 2015 Nov; 75(22):4803-16. PubMed ID: 26383163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism.
    M Onorato A; Fiore E; Bayo J; Casali C; Fernandez-Tomé M; Rodríguez M; Domínguez L; Argemi J; Hidalgo F; Favre C; García M; Atorrasagasti C; Mazzolini GD
    Liver Int; 2021 Jul; 41(7):1677-1693. PubMed ID: 33641248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome.
    Pribadi C; Camp E; Cakouros D; Anderson P; Glackin C; Gronthos S
    Stem Cell Res Ther; 2020 Dec; 11(1):529. PubMed ID: 33298158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
    Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
    BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy, NAFLD and NAFLD-Related HCC.
    Wu WKK; Zhang L; Chan MTV
    Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
    Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone demethylase KDM6B promotes epithelial-mesenchymal transition.
    Ramadoss S; Chen X; Wang CY
    J Biol Chem; 2012 Dec; 287(53):44508-17. PubMed ID: 23152497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
    Chi Y; Gong Z; Xin H; Wang Z; Liu Z
    J Transl Med; 2020 Mar; 18(1):126. PubMed ID: 32169080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
    Song Q; Zhang X; Liu W; Wei H; Liang W; Zhou Y; Ding Y; Ji F; Ho-Kwan Cheung A; Wong N; Yu J
    J Hepatol; 2023 Dec; 79(6):1352-1365. PubMed ID: 37459922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells.
    Zhang PP; Wang XL; Zhao W; Qi B; Yang Q; Wan HY; Shuang ZY; Liu M; Li X; Li S; Tang H
    J Biol Chem; 2014 Aug; 289(35):24724-35. PubMed ID: 25049231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defects in long-chain 3-hydroxy acyl-CoA dehydrogenase lead to hepatocellular carcinoma: A novel etiology of hepatocellular carcinoma.
    Khare T; Khare S; Angdisen JJ; Zhang Q; Stuckel A; Mooney BP; Ridenhour SE; Gitan RS; Hammoud GM; Ibdah JA
    Int J Cancer; 2020 Sep; 147(5):1461-1473. PubMed ID: 32115688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of G0/G1 Switch Gene 2 (G0S2) Protein Ubiquitination and Stability by Triglyceride Accumulation and ATGL Interaction.
    Heckmann BL; Zhang X; Saarinen AM; Liu J
    PLoS One; 2016; 11(6):e0156742. PubMed ID: 27248498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.